ALT FY 2022 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$353M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$68,000-101.5% YoY

Gross Profit

-$68,000100.0% margin

Operating Income

-$88M129029.4% margin

Net Income

-$85M124577.9% margin

EPS (Diluted)

$-1.81

Cash Flow

Operating Cash Flow

-$63M

Free Cash Flow

-$63M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$207M

Total Liabilities

$22M

Stockholders' Equity

$185M

Cash & Equivalents

$111M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$68,000	$4M	-101.5%
Gross Profit	-$68,000	$4M	-101.5%
Operating Income	-$88M	-$97M	+9.5%
Net Income	-$85M	-$97M	+12.7%